
Dr. Lakshi Aldredge sets the record straight regarding common misconceptions about prurigo nodularis.
Dr. Ahuva Cices provides key pathophysiologic insights and dispels common misconceptions surrounding atopic dermatitis.

Join Dr. Jason Hawkes as he explains the importance of type 2 inflammation in chronic spontaneous urticaria.

Listen as Dr. Donna Culton discusses the importance of crosstalk between autoantibodies and type 2 inflammation in the development of bullous pemphigoid.

In this webinar, Drs. David Cotter, Daniel Butler, and Walter Liszewski share key clinical insights, highlighting the central role of type 2 inflammation across atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria while addressing prevalent scientific misconceptions.
Dr. David Cotter discusses how atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis present uniquely in practice—and how type 2 inflammation links these distinct disease states.

Dr Mario Castro explains how type 2 cytokines play a crucial role in airway remodeling and inflammation in asthma and COPD, impacting patient outcomes.

Join Dr. Hawkes as he discusses what burdens and challenges CSU patients might expect and help identify that there are immune functions responsible for their symptoms not an external cause.

Join Dr Kwatra as he dives deeper into the mechanism of lesion formation in Prurigo Nodularis and the impact the development of these skin lesions have on patient life.

Dr. Daniel Butler tackles prevalent misconceptions surrounding prurigo nodularis.

Dr. Walter Liszewski sheds light on chronic spontaneous urticaria by untangling widespread misconceptions.

Learn more about how the exaggerated immune response due to chronic and systemic type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis